Skip to main content

New drug approved for duchenne muscular dystrophy

The U.S. Food and Drug Administration approved a drug for all patients with child onset muscular dystrophy, serving as the first of its kind.

by Cassandra Pollock

Lead image for this article
Credit: Maria Kaloudi

The U.S. Food and Drug Administration approved a drug for all patients with child onset muscular dystrophy, the second drug approved for the disease and the first for everyone with the disorder. (Chicago Tribune)

Information about the authors

Cassandra Pollock’s staff photo

Quality journalism doesn't come free

Perhaps it goes without saying — but producing quality journalism isn't cheap. At a time when newsroom resources and revenue across the country are declining, The Texas Tribune remains committed to sustaining our mission: creating a more engaged and informed Texas with every story we cover, every event we convene and every newsletter we send. As a nonprofit newsroom, we rely on members to help keep our stories free and our events open to the public. Do you value our journalism? Show us with your support.

Yes, I'll donate today